Current News

Contact | Print version | Send article | RSS feed

Gilead licenses Manufacturing and Distribution of Generic Versions of Viread to India-Based Companies

16 Aug 2006 - Gilead Sciences, Inc. announced that the company has signed non-exclusive license agreements to provide generic versions of tenofovir disoproxil fumarate (sold by Gilead under the brand name Viread(R)) to three generic manufacturers in India. These license agreements grant to Emcure Pharmaceuticals Ltd., Hetero Drugs Ltd. and Strides Arcolab Ltd. the rights to produce and distribute generic versions of tenofovir to 95 low-income countries around the world, including India.
 
The license agreements require that the generic manufacturers meet certain national and international regulatory standards and include a technology transfer to enable expeditious production of large volumes of high-quality generic versions of tenofovir. In addition, these agreements allow the manufacture of commercial quantities of both active pharmaceutical ingredient (API) and finished product. Gilead continues to pursue license agreements with additional Indian generic manufacturers and is currently in ongoing discussions with a number of Indian companies.